Dolby Laboratories, Inc.

Dolby Laboratories, Inc. has recently revised its evaluation amid challenging market conditions, with its stock priced at $61.09. Over the past year, the company has experienced a significant decline, underperforming compared to the S&P 500. Technical indicators suggest a bearish sentiment, emphasizing the need for strategic adjustments.

Dolby Laboratories, Inc. has hit a new 52-week low, with its stock price significantly declining over the past year. The company faces financial challenges, including reduced profits and low cash reserves, while its market capitalization stands at approximately USD 5,846 million, indicating ongoing struggles in performance.

Dolby Laboratories, Inc. has recently adjusted its valuation, with a P/E ratio of 23 and a price-to-book value of 2.25. Key metrics include an EV to EBIT of 19.17 and a dividend yield of 2.04%. The company has faced challenges, reflected in a one-year return of -28.91%.

Dolby Laboratories, Inc. has hit a new 52-week low, reflecting a significant decline in its stock price over the past year. The company faces stagnant growth, with modest annual sales and profit increases, while recent quarterly results show notable declines in pre-tax and net profits. Its valuation appears high compared to peers.

Dolby Laboratories, Inc. has reached a 52-week low, trading at USD 58.39, reflecting a 25.58% decline over the past year. The company has a market capitalization of USD 5,846 million, a P/E ratio of 23.00, and has faced challenges with stagnant growth and declining profits.

Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 59.41. The company has experienced a 24.59% decline in stock price over the past year, with financial metrics indicating challenges, including reduced profits and low cash reserves, amidst a competitive market environment.

Dolby Laboratories, Inc. has recently adjusted its valuation, with its stock price at $60.33, down from $61.50. Over the past year, the company has experienced a significant decline in stock return, underperforming the S&P 500. Key financial metrics indicate a stable position relative to competitors in the software sector.

Dolby Laboratories, Inc. has recently adjusted its valuation, with a P/E ratio of 24 and a price-to-book value of 2.53. The company demonstrates operational efficiency through its EV to EBIT and EV to EBITDA ratios. Despite a decline in stock performance, its financial metrics indicate a competitive position in the software products industry.

Dolby Laboratories, Inc. has hit a new 52-week low, reflecting an 18.4% decline in stock price over the past year. The company faces financial challenges, including decreased profits and stagnant growth, while its market capitalization is approximately USD 7 billion. Institutional holdings remain high at 100%.

Dolby Laboratories, Inc. has reached a 52-week low, trading at USD 64.38 as of November 7, 2025, following a 17.7% decline in stock price over the past year. The company faces challenges with declining profits and flat sales growth, despite strong institutional interest and a notable market capitalization.

Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.50 as of October 30, 2025. The company has experienced a 17% decline in stock price over the past year, with recent financial results showing significant decreases in pre-tax and net profits, alongside flat sales growth.

Dolby Laboratories, Inc. has hit a new 52-week low, trading at USD 64.56. The company, with a market capitalization of USD 7,024 million, faces challenges including declining profits and modest sales growth. Its financial metrics reveal a P/E ratio of 27.00 and a low cash position of USD 1,507.67 million.

Dolby Laboratories, Inc. has hit a new 52-week low, with its stock price declining significantly over the past year. The company reported decreases in pre-tax and net profits, while cash reserves have also diminished. Despite flat growth in sales and operating profit, institutional investors have shown increased interest.

Dolby Laboratories, Inc. has recently adjusted its valuation, with a P/E ratio of 27 and a price-to-book value of 2.80. Key financial metrics include an EV to EBIT of 22.83 and a PEG ratio of 2.73, showcasing its operational efficiency and competitive position within the software industry.

Dolby Laboratories, Inc. has reached a 52-week low of USD 67.54, reflecting a notable decline in its stock price over the past year. The company faces challenges in growth, with modest increases in net sales and operating profit, alongside significant drops in quarterly profits.

Dolby Laboratories, Inc. has hit a new 52-week low, reflecting a notable decline in its stock price over the past year. The company reported significant drops in pre-tax and net profits, alongside a modest annual sales growth rate. Its financial metrics suggest a challenging environment for the small-cap software firm.